Institutional Biosafety/recombinant DNA Committee (IBC) Charter
 
I. Introduction | II. Roles and Responsibilities | III. Research | IV. IBC Membership | V. IBC Policies and Procedures | VI. Protocol Review Process
 
Show as single page
III. Research

Research covered by this policy will fall into one of the following four categories.

  1. rDNA (Recombinant or synthetic nucleic acids):
    • Molecules that are constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell;
    • Molecules that replicate as a result of the above.
  2. RG2 (Risk Group 2): Agents that are associated with diseases that are rarely serious and for which preventive/therapeutic interventions are often available.
  3. RG3 (Risk Group 3): Agents that are associated with serious/lethal human diseases for which preventive/therapeutic interventions may be available (high individual risk, but low community risk).
  4. RG4 (Risk Group 4): Agents that are likely to cause serious/lethal human diseases for which preventive/therapeutic interventions are not usually available (high individual risk and high community risk).

 


II. Roles and Responsibilities | Page 3 of 6 | IV. IBC Membership



   
News & Events

   
Links

The University of Texas at El Paso  |  Terms Of Use  |  Privacy Statement  |  Required Links